Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension.

ABSTRACT:

SUBMITTER: Clement Freiberg J 

PROVIDER: S-EPMC9185806 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature